Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$114.22 - $140.1 $90,348 - $110,819
-791 Reduced 5.99%
12,422 $1.72 Million
Q4 2023

Feb 12, 2024

SELL
$75.49 - $124.16 $8,530 - $14,030
-113 Reduced 0.85%
13,213 $1.64 Million
Q3 2023

Nov 09, 2023

SELL
$86.06 - $137.93 $22,117 - $35,448
-257 Reduced 1.89%
13,326 $1.16 Million
Q2 2023

Aug 08, 2023

SELL
$112.47 - $130.98 $131,814 - $153,508
-1,172 Reduced 7.94%
13,583 $1.75 Million
Q1 2023

May 04, 2023

SELL
$104.0 - $122.92 $22,256 - $26,304
-214 Reduced 1.43%
14,755 $1.71 Million
Q4 2022

Feb 08, 2023

SELL
$84.98 - $122.67 $158,657 - $229,024
-1,867 Reduced 11.09%
14,969 $1.7 Million
Q3 2022

Nov 08, 2022

SELL
$76.35 - $94.18 $14,201 - $17,517
-186 Reduced 1.09%
16,836 $1.36 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $862,113 - $1.69 Million
12,680 Added 292.03%
17,022 $1.27 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $25,777 - $35,674
274 Added 6.74%
4,342 $2.22 Million
Q4 2021

Feb 15, 2022

BUY
$129.87 - $162.82 $12,597 - $15,793
97 Added 2.44%
4,068 $2.18 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $21,128 - $28,349
198 Added 5.25%
3,971 $2.17 Million
Q2 2021

Aug 09, 2021

BUY
$80.99 - $107.93 $15,793 - $21,046
195 Added 5.45%
3,773 $402,000
Q1 2021

May 18, 2021

BUY
$84.79 - $104.74 $30,439 - $37,601
359 Added 11.15%
3,578 $1.29 Million
Q4 2020

Feb 09, 2021

BUY
$78.0 - $104.5 $72,384 - $96,976
928 Added 40.51%
3,219 $1.19 Million
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $33,524 - $39,645
351 Added 18.09%
2,291 $940,000
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $1,002 - $1,685
16 Added 0.83%
1,940 $786,000
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $90,753 - $143,621
1,899 Added 7596.0%
1,924 $518,000
Q2 2019

Aug 12, 2019

BUY
$27.84 - $38.92 $696 - $973
25 New
25 $4,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.